Fintel reports that on February 14, 2025, UBS initiated coverage of Alvotech (NasdaqGM:ALVO) with a Buy recommendation.

Fintel reports that on February 14, 2025, UBS downgraded their outlook for enGene Holdings (NasdaqCM:ENGN) from Buy to Neutral. Analyst Price Forecast Suggests 382.56% Upside As of January 28, 2025, ...

Shares of QuidelOrtho Co. (NASDAQ:QDEL – Get Free Report) gapped up before the market opened on Thursday after UBS Group raised their price target on the stock from $43.00 to $45.00. The stock had ...

Despite continued demand for electric vehicles (EVs), Tesla’s performance was overshadowed by rising competition, ...

President Donald Trump announced his administration will study reciprocal tariffs, but stopped short of implementing them at ...

He believes that the next generation of AI is the application layer, with companies creating new services using AI models, ...

In addition, further weakness in the euro - UBS sees it falling to $0.99 by the end of 2025 - would be consistent with improving earnings revisions. A 10% fall in the euro may increase European ...

The French luxury group reported better-than-expected sales on Friday, pushing its market cap above 300 billion euros for the ...

Shares of Palo Alto Networks sank Friday morning despite the cybersecurity firm's results for the second quarter of fiscal ...

CNBC projected that the emergence of cheaper AI models from China could increase the demand for data centers. Analysts ...